Gut Microbiome May Be a Factor With Immunotherapy Resistance in Advanced Melanoma

Elisa Becze BA, ELS, Editor


Altering a patient's gut microbiome through fecal transplant improved response to immune checkpoint inhibitor therapy in 40% of patients with advanced melanoma who initially did not respond to the immunotherapy in a small, single-arm clinical trial. Researchers reported the findings in Science.

View Article @

ONS Voice Articles

Dive into a rich source of oncology nursing expertise with ONS articles.

View All Voice Articles